WHO clinical criteria-based initiation of antiretroviral therapy: Lessons from rural district hospitals in Cameroon with regard to 2009 revised WHO recommendations

Tropical Medicine and International Health

Volumn 15, Issue 5, 2010, Pages 580-583

  Kouanfack, Charles ^a   Laborde Balen, Gabrièle ^b   Aghokeng, Avelin F ^c,d   Bourgeois, Anke ^c,e   Dontsop, Marlise ^d   Mben, Jean Marc ^d   Kazé, Serge ^d   Mpoudi Ngolé, Eitel ^d   Koulla Shiro, Sinata ^a   Delaporte, Eric ^c,e   Laurent, Christian ^c  

^a YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^b French Ministry of Foreign Affairs   (Cameroon)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

Africa; Antiretroviral therapy; HIV; World Health Organization criteria

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

DISEASE SPREAD; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; WORLD HEALTH ORGANIZATION;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PUBLIC HOSPITAL; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CAMEROON; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DRUG MONITORING; FEMALE; GUIDELINES AS TOPIC; HIV INFECTIONS; HOSPITALS, DISTRICT; HOSPITALS, RURAL; HUMANS; MALE; WORLD HEALTH ORGANIZATION;

CAMEROON;

EID: 77950646631     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02495.x     Document Type: Article

References (13)

1. Bourgeois A, Laurent C, Mougnutou R et al. (2005) Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon. Antiviral Therapy 10, 335 341. (Pubitemid 41151040)
2. Jaffar S, Birungi J, Grosskurth H et al. (2008) Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda. AIDS Research and Therapy 5, 4.
3. Kitahata MM, Gange SJ, Abraham AG et al. (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine 360, 1815 1826.
4. Laurent C, Kouanfack C, Koulla-Shiro S et al. (2004) Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 364, 29 34.
5. Laurent C, Meilo H, Guiard-Schmid JB et al. (2005) Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Clinical Infectious Diseases 41, 108 111.
6. Ministry of Public Health (2004) Plan De Décentralisation De La Prise En Charge Par Les Antirétroviraux Au Cameroun (2004-2005). MoPH
7. Ministry of Public Health (2007) Directives Nationales De Prise En Charge Des Personnes Vivant Avec Le Vih Par Les Antirétroviraux. MoPH
8. Sterne JA, May M, Costagliola D et al. (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373, 1352 1363.
9. Walensky RP, Wolf LL, Wood R et al. (2009) When to start antiretroviral therapy in resource-limited settings. Annals of Internal Medicine 151, 157 166.
10. World Health Organisation (2006b) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2006 revision. http://www.who.int/hiv/pub/guidelines/ artadultguidelines.pdf.
11. World Health Organization (2006a) Towards universal access by 2010. How WHO is working with countries to scale-up HIV prevention, treatment, care and support. http://www.who.int/hiv/toronto2006/towardsuniversalaccess.pdf.
12. World Health Organization (2009a) Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009. http://www.who.int/hiv/pub/tuapr-2009-en.pdf.
13. World Health Organization (2009b) Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents. http://www.who.int/hiv/pub/arv/ rapid-advice-art.pdf.